Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours

被引:30
作者
Mangham, D. Charles [1 ,2 ]
Athanasou, Nicholas A. [3 ]
机构
[1] Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Musculoskeletal Pathol, Oswestry SY10 7AG, Shrops, England
[2] Royal Orthopaed Hosp, Dept Musculoskeletal Pathol, Birmingham B31 2AP, W Midlands, England
[3] Univ Oxford, NDORMS, Nuffield Orthopaed Ctr, Dept Pathol, Oxford OX3 7LD, England
关键词
D O I
10.1186/2045-3329-1-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review is intended to provide histopathologists with guidelines for clinical assessment, specimen handling and diagnostic reporting of benign and malignant primary bone tumours. Information from radiology, surgical, oncology and other clinical colleagues involved in the diagnosis and treatment of primary bone tumours should be properly assessed before undertaking a structured approach to specimen handling and histological reporting. This ensures that the information needed for planning appropriate treatment of these complex tumours is provided. Consistency in diagnostic evaluation with respect to both terminology and report content facilitates liaison at multidisciplinary bone tumour meetings and collaboration between cancer units and networks, as well as providing a common database for audit of the clinical, radiological and pathological aspects of bone tumours.
引用
收藏
页数:13
相关论文
共 74 条
[11]  
Craver RD, 1996, ORTHOP CLIN N AM, V27, P461
[12]   PROGNOSTIC FACTORS IN OSTEOSARCOMA - A CRITICAL-REVIEW [J].
DAVIS, AM ;
BELL, RS ;
GOODWIN, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :423-431
[13]  
Edge SB, 2009, AJCC CANC STAGING MA
[14]  
ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9
[15]  
EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO
[16]  
2-B
[17]  
Fechner R E, 1984, Pathol Annu, V19 Pt 1, P125
[18]   Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma [J].
Feugeas, O ;
Guriec, N ;
BabinBoilletot, A ;
Marcellin, L ;
Simon, P ;
Babin, S ;
Thyss, A ;
Hofman, P ;
Terrier, P ;
Kalifa, C ;
BrunatMentigny, M ;
Patricot, LM ;
Oberling, F .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :467-472
[19]  
Fletcher CDM, 2002, PATHOLOGY GENETICS T
[20]   Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics [J].
Folpe, AL ;
Chand, EM ;
Goldblum, JR ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (08) :1061-1066